Targeting FAM64A: a promising strategy to halt liver cancer angiogenesis and enhance immunity

Liping Bai, Xueyan Yang, Lixian Bai, Zhongkun Ren, Hong Gong, Yinghui Zhang, Han Chen, Zhijian Ma

Open source

DOI
10.62347/hfgx2343
Published
2026
Container
American Journal of Cancer Research
Publisher
e-Century Publishing Corporation
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.62347/hfgx2343,
  title = {Targeting FAM64A: a promising strategy to halt liver cancer angiogenesis and enhance immunity},
  author = {Liping Bai and Xueyan Yang and Lixian Bai and Zhongkun Ren and Hong Gong and Yinghui Zhang and Han Chen and Zhijian Ma},
  year = {2026},
  journal = {American Journal of Cancer Research},
  doi = {10.62347/hfgx2343},
  url = {https://doi.org/10.62347/hfgx2343}
}

RIS

TY  - JOUR
TI  - Targeting FAM64A: a promising strategy to halt liver cancer angiogenesis and enhance immunity
AU  - Liping Bai
AU  - Xueyan Yang
AU  - Lixian Bai
AU  - Zhongkun Ren
AU  - Hong Gong
AU  - Yinghui Zhang
AU  - Han Chen
AU  - Zhijian Ma
PY  - 2026
JO  - American Journal of Cancer Research
DO  - 10.62347/hfgx2343
UR  - https://doi.org/10.62347/hfgx2343
ER  - 

APA

Bai, L., Yang, X., Bai, L., Ren, Z., Gong, H., Zhang, Y., Chen, H., & Ma, Z. (2026). Targeting FAM64A: a promising strategy to halt liver cancer angiogenesis and enhance immunity. American Journal of Cancer Research. https://doi.org/10.62347/hfgx2343

Source records